Theriva Biologics's total assets for Q2 2026 were $34.86M, a decrease of -8.87% from the previous quarter. DE:SFY0 total liabilities were $22.67M for the fiscal quarter, a -0.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.